SIMILAR PATTERN OF AMINO ACIDS MAPPED TO '4tyh'

List of Similar Pattern of Amino Acids

Hit pattern: 3D amino acid arrangements similar to known drug binding site
Query pattern: Residues from known binding site for annotated drug that match the hit pattern

(Click on the DrReposER ID to view details on interfaces and similar patterns of amino acids)
(Click on the view link on the last column to view superposed patterns of amino acids)

Filter list by:

	DrReposER ID / Desc.	Hit PDBID	Hit Macromolecule	Res. Matches	Interface	HETATM	RMSD	Dali Z-score	Seq. Identity (%)
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_C_THAC3_1 (LIVER CARBOXYLESTERASE I)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	VAL B 102 LEU B 55 LEU B 75 LEU B 104 LEU B 74	None None 39G B 401 (-4.3A) 39G B 401 ( 4.7A) None	0.93A	1mx1C-4tyhB: undetectable	1mx1C-4tyhB: 20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1MX1_F_THAF6_1 (LIVER CARBOXYLESTERASE I)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	VAL B 102 LEU B 55 LEU B 75 LEU B 104 LEU B 74	None None 39G B 401 (-4.3A) 39G B 401 ( 4.7A) None	1.06A	1mx1F-4tyhB: undetectable	1mx1F-4tyhB: 20.86
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	1XKK_A_FMMA91_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 9	VAL B 38 LYS B 53 LEU B 86 LEU B 104 LEU B 108 MET B 109	None 39G B 401 (-4.2A) None 39G B 401 ( 4.7A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A)	0.68A	1xkkA-4tyhB: 20.6	1xkkA-4tyhB: 25.65
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IDK_A_C2FA1410_0 (GLYCINE N-METHYLTRANSFERASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 11	LEU B 232 HIS B 228 SER B 254 TYR B 258 LEU B 236	None	1.49A	2idkA-4tyhB: undetectable 2idkB-4tyhB: undetectable 2idkC-4tyhB: undetectable 2idkD-4tyhB: undetectable	2idkA-4tyhB: 22.19 2idkB-4tyhB: 22.19 2idkC-4tyhB: 22.19 2idkD-4tyhB: 22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2IDK_B_C2FB1420_0 (GLYCINE N-METHYLTRANSFERASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 10	LEU B 236 SER B 254 TYR B 258 LEU B 232 HIS B 228	None	1.36A	2idkA-4tyhB: 1.2 2idkB-4tyhB: 1.2 2idkC-4tyhB: 0.0 2idkD-4tyhB: 1.3	2idkA-4tyhB: 22.19 2idkB-4tyhB: 22.19 2idkC-4tyhB: 22.19 2idkD-4tyhB: 22.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2ITZ_A_IREA2021_2 (EPIDERMAL GROWTH FACTOR RECEPTOR)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	3 / 3	LEU B 104 LEU B 108 MET B 109	39G B 401 ( 4.7A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A)	0.51A	2itzA-4tyhB: 21.7	2itzA-4tyhB: 25.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	2QD2_A_CHDA426_0 (FERROCHELATASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	4 / 4	LEU B 246 PRO B 242 LEU B 291 ARG B 296	None	1.38A	2qd2A-4tyhB: undetectable	2qd2A-4tyhB: 22.20
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3CD2_A_MTXA307_1 (DIHYDROFOLATE REDUCTASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	ILE B 131 LEU B 289 ILE B 206 LEU B 151 ILE B 212	None	1.16A	3cd2A-4tyhB: undetectable	3cd2A-4tyhB: 19.32
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 12	GLU B 71 LEU B 74 LEU B 75 THR B 106 LEU B 167 ASP B 168	39G B 401 (-3.4A) None 39G B 401 (-4.3A) 39G B 401 (-3.6A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	1.26A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	LEU B 75 ILE B 84 THR B 106 LEU B 167 ASP B 168	39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	0.95A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	9 / 12	VAL B 38 ALA B 51 GLU B 71 LEU B 74 LEU B 75 THR B 106 ILE B 141 HIS B 148 LEU B 167	None 39G B 401 (-3.5A) 39G B 401 (-3.4A) None 39G B 401 (-4.3A) 39G B 401 (-3.6A) None None 39G B 401 (-3.6A)	0.95A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	8 / 12	VAL B 38 ALA B 51 LEU B 75 ILE B 84 THR B 106 ILE B 141 HIS B 148 LEU B 167	None 39G B 401 (-3.5A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None None 39G B 401 (-3.6A)	0.81A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	VAL B 117 LEU B 164 ILE B 134 ILE B 141 HIS B 148	None	0.90A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 6	MET B 78 VAL B 83 LEU B 108 ILE B 146 ILE B 166	None None 39G B 401 ( 4.9A) None None	0.62A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GCS_A_BAXA401_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 6	MET B 78 VAL B 83 LEU B 108 MET B 109 ILE B 166	None None 39G B 401 ( 4.9A) 39G B 401 (-4.8A) None	1.07A	3gcsA-4tyhB: 29.9	3gcsA-4tyhB: 98.28
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	8 / 12	ALA B 51 GLU B 71 LEU B 74 LEU B 75 ILE B 84 ALA B 157 LEU B 167 ASP B 168	39G B 401 (-3.5A) 39G B 401 (-3.4A) None 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 ( 4.9A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	1.08A	3gp0A-4tyhB: 41.1	3gp0A-4tyhB: 75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	8 / 12	ALA B 51 GLU B 71 LEU B 74 LEU B 75 ILE B 84 HIS B 148 ALA B 157 LEU B 167	39G B 401 (-3.5A) 39G B 401 (-3.4A) None 39G B 401 (-4.3A) 39G B 401 ( 3.8A) None 39G B 401 ( 4.9A) 39G B 401 (-3.6A)	0.85A	3gp0A-4tyhB: 41.1	3gp0A-4tyhB: 75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	9 / 12	VAL B 38 ALA B 51 LEU B 74 LEU B 75 ILE B 84 THR B 106 ALA B 157 LEU B 167 ASP B 168	None 39G B 401 (-3.5A) None 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	0.98A	3gp0A-4tyhB: 41.1	3gp0A-4tyhB: 75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3GP0_A_NILA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 11)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	9 / 12	VAL B 38 ALA B 51 LEU B 74 LEU B 75 ILE B 84 THR B 106 HIS B 148 ALA B 157 LEU B 167	None 39G B 401 (-3.5A) None 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None 39G B 401 ( 4.9A) 39G B 401 (-3.6A)	0.90A	3gp0A-4tyhB: 41.1	3gp0A-4tyhB: 75.00
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	GLU B 71 LEU B 75 ILE B 84 LEU B 167 ASP B 168	39G B 401 (-3.4A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	0.79A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	LEU B 75 ILE B 84 THR B 106 LEU B 167 ASP B 168	39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	0.81A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 12	LYS B 53 ILE B 84 THR B 106 LEU B 108 LEU B 167 ASP B 168	39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	0.85A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 ALA B 51 LEU B 74 ILE B 84 THR B 106 LEU B 108 LEU B 167	None 39G B 401 (-3.5A) None 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A) 39G B 401 (-3.6A)	0.59A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 ALA B 51 LEU B 74 LEU B 75 ILE B 84 THR B 106 LEU B 167	None 39G B 401 (-3.5A) None 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.6A)	0.63A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 ALA B 51 LYS B 53 ILE B 84 THR B 106 LEU B 108 LEU B 167	None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A) 39G B 401 (-3.6A)	0.65A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEC_A_STIA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 12	VAL B 30 GLU B 71 LEU B 74 LEU B 75 ILE B 84 LEU B 167	None 39G B 401 (-3.4A) None 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A)	0.66A	3hecA-4tyhB: 41.0	3hecA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 VAL B 38 ALA B 51 GLU B 71 LEU B 74 LEU B 75 ILE B 141	None None 39G B 401 (-3.5A) 39G B 401 (-3.4A) None 39G B 401 (-4.3A) None	0.84A	3hegA-4tyhB: 42.1	3hegA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 VAL B 38 ALA B 51 LEU B 74 LEU B 75 THR B 106 ILE B 141	None None 39G B 401 (-3.5A) None 39G B 401 (-4.3A) 39G B 401 (-3.6A) None	0.69A	3hegA-4tyhB: 42.1	3hegA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 VAL B 38 ALA B 51 LEU B 75 ILE B 84 THR B 106 ILE B 141	None None 39G B 401 (-3.5A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None	0.57A	3hegA-4tyhB: 42.1	3hegA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 12	VAL B 38 ALA B 51 LYS B 53 ILE B 84 THR B 106 ILE B 141	None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None	0.84A	3hegA-4tyhB: 42.1	3hegA-4tyhB: 99.42
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3HEG_A_BAXA1_2 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 6	MET B 78 VAL B 83 ILE B 146 HIS B 148 ILE B 166 LEU B 167	None None None None None 39G B 401 (-3.6A)	0.63A	3hegA-4tyhB: 42.1	3hegA-4tyhB: 99.42
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3IA4_A_MTXA164_1 (DIHYDROFOLATE REDUCTASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	ALA B 302 GLN B 133 SER B 208 ILE B 212 LEU B 216	None	1.37A	3ia4A-4tyhB: undetectable	3ia4A-4tyhB: 17.28
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3JW3_A_TOPA208_1 (DIHYDROFOLATE REDUCTASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 10	ALA B 302 LEU B 138 ILE B 212 LEU B 156 ILE B 131	None	1.08A	3jw3A-4tyhB: undetectable	3jw3A-4tyhB: 17.97
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 8	ALA B 51 LYS B 53 THR B 106 LEU B 108 MET B 109	39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A)	0.61A	3lfaA-4tyhB: 42.6	3lfaA-4tyhB: 99.43
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3LFA_A_1N1A361_1 (MITOGEN-ACTIVATED PROTEIN KINASE 14)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 8	VAL B 30 ALA B 51 LEU B 104 THR B 106 LEU B 108 MET B 109	None 39G B 401 (-3.5A) 39G B 401 ( 4.7A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A)	0.54A	3lfaA-4tyhB: 42.6	3lfaA-4tyhB: 99.43
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3OG7_A_032A1_1 (AKAP9-BRAF FUSION PROTEIN)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	VAL B 38 ALA B 51 LYS B 53 LEU B 75 THR B 106	None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 (-4.3A) 39G B 401 (-3.6A)	0.70A	3og7A-4tyhB: 19.2	3og7A-4tyhB: 25.91
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	GLY B 31 VAL B 38 ALA B 51 LEU B 75 ILE B 84 THR B 106 ASN B 114	None None 39G B 401 (-3.5A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None	1.46A	3ohtA-4tyhB: 34.3	3ohtA-4tyhB: 86.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	9 / 12	VAL B 30 GLY B 31 VAL B 38 ALA B 51 LYS B 53 LEU B 75 ILE B 84 THR B 106 LEU B 167	None None None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.6A)	0.86A	3ohtA-4tyhB: 34.3	3ohtA-4tyhB: 86.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	VAL B 30 GLY B 31 VAL B 38 LYS B 53 ILE B 84 LEU B 167 ASP B 168	None None None 39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.5A)	1.21A	3ohtA-4tyhB: 34.3	3ohtA-4tyhB: 86.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_A_1N1A1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	9 / 12	VAL B 30 VAL B 38 ALA B 51 LYS B 53 LEU B 75 ILE B 84 THR B 106 ASN B 115 LEU B 167	None None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None 39G B 401 (-3.6A)	0.86A	3ohtA-4tyhB: 34.3	3ohtA-4tyhB: 86.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	7 / 12	GLY B 31 VAL B 38 ALA B 51 LYS B 53 ILE B 84 THR B 106 LEU B 167	None None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 (-3.6A)	0.77A	3ohtB-4tyhB: 34.3	3ohtB-4tyhB: 86.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	VAL B 38 ALA B 51 LEU B 75 ILE B 84 LEU B 167	None 39G B 401 (-3.5A) 39G B 401 (-4.3A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A)	0.45A	3ohtB-4tyhB: 34.3	3ohtB-4tyhB: 86.49
Available target for annotated drug, i.e. matched protein structure has more than 30% sequence identity to known drug target.	3OHT_B_1N1B1000_1 (P38A)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	6 / 12	VAL B 38 ALA B 51 LYS B 53 ILE B 84 THR B 106 ASN B 115	None 39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) None	0.85A	3ohtB-4tyhB: 34.3	3ohtB-4tyhB: 86.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3PGL_A_RZXA257_1 (CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTIDE A SMALL PHOSPHATASE 1)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 7	PHE B 169 VAL B 83 ILE B 166 SER B 143 TYR B 140	None	1.42A	3pglA-4tyhB: undetectable	3pglA-4tyhB: 20.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3QL0_A_FOLA160_0 (DIHYDROFOLATE REDUCTASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	ALA B 302 MET B 288 LEU B 138 ILE B 212 LEU B 156	None	1.07A	3ql0A-4tyhB: undetectable	3ql0A-4tyhB: 17.24
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	3UJ6_A_SAMA300_1 (PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	4 / 4	SER B 56 ASP B 168 ASP B 112 ALA B 34	None 39G B 401 (-3.5A) None None	1.37A	3uj6A-4tyhB: undetectable	3uj6A-4tyhB: 21.49
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4K50_I_ACTI507_0 (RNA POLYMERASE 3D-POL)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	3 / 3	LYS B 152 PRO B 153 SER B 154	None	0.43A	4k50I-4tyhB: 0.8	4k50I-4tyhB: 21.83
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4O8Z_A_BBIA402_1 (NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	4 / 5	PHE B 42 HIS B 48 LEU B 87 PRO B 351	None	1.30A	4o8zA-4tyhB: undetectable	4o8zA-4tyhB: 21.87
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4OU1_A_BEZA302_0 (RETRO-ALDOLASE, DESIGN RA114)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	4 / 8	LYS B 118 ILE B 116 ASN B 115 ALA B 111	None	0.91A	4ou1A-4tyhB: undetectable	4ou1A-4tyhB: 22.69
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4RZ7_A_1E8A901_1 (CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 10	ALA B 51 LYS B 53 ILE B 84 THR B 106 LEU B 108	39G B 401 (-3.5A) 39G B 401 (-4.2A) 39G B 401 ( 3.8A) 39G B 401 (-3.6A) 39G B 401 ( 4.9A)	0.83A	4rz7A-4tyhB: 17.6	4rz7A-4tyhB: 18.19
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	4UXQ_A_0LIA1752_2 (FIBROBLAST GROWTH FACTOR RECEPTOR 4)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	4 / 7	VAL B 38 LYS B 53 ILE B 84 ILE B 166	None 39G B 401 (-4.2A) 39G B 401 ( 3.8A) None	0.79A	4uxqA-4tyhB: 21.3	4uxqA-4tyhB: 27.04
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5HBS_A_RTLA201_1 (RETINOL-BINDING PROTEIN 1)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	4 / 8	LEU B 75 LEU B 167 TYR B 140 GLN B 202	39G B 401 (-4.3A) 39G B 401 (-3.6A) None None	1.19A	5hbsA-4tyhB: undetectable	5hbsA-4tyhB: 17.95
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_E_ADNE401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 10	GLY B 31 VAL B 38 ALA B 51 LEU B 108 MET B 109	None None 39G B 401 (-3.5A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A)	0.77A	5lw1E-4tyhB: 36.8	5lw1E-4tyhB: 11.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 9	GLY B 31 ALA B 51 LEU B 108 MET B 109 LEU B 167	None 39G B 401 (-3.5A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A) 39G B 401 (-3.6A)	0.80A	5lw1H-4tyhB: 15.5	5lw1H-4tyhB: 11.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5LW1_H_ADNH401_1 (MITOGEN-ACTIVATED PROTEIN KINASE 8)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 9	GLY B 31 VAL B 38 ALA B 51 LEU B 108 MET B 109	None None 39G B 401 (-3.5A) 39G B 401 ( 4.9A) 39G B 401 (-4.8A)	0.77A	5lw1H-4tyhB: 15.5	5lw1H-4tyhB: 11.21
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5YCN_A_8LXA501_0 (PEROXISOME PROLIFERATOR-ACTIVAT ED RECEPTOR GAMMA)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	5 / 12	LEU B 138 ILE B 206 GLY B 210 ILE B 131 LEU B 238	None	0.90A	5ycnA-4tyhB: undetectable	5ycnA-4tyhB: 21.80
Potential target for repurposing, i.e. matched protein structure has less than 30% sequence identity to known drug target, and may potentially interact with the same drug molecule based on local structural similarity of binding site.	5ZW2_A_ACTA511_0 (L-PROLYL-[PEPTIDYL-C ARRIER PROTEIN] DEHYDROGENASE)	4tyh	MITOGEN-ACTIVATED PROTEIN KINASE 14 (Mus musculus)	3 / 3	ARG B 256 ILE B 250 SER B 252	None	0.84A	5zw2A-4tyhB: undetectable	5zw2A-4tyhB: 22.72

[["DrReposER ID","Desc.","Hit PDB","Hit molecule","Hit organism","Res. no.","Interface","HETATM","RMSD","Z-score","Seq ID"],["1MX1_C_THAC3_1","LIVER CARBOXYLESTERASE I","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"VAL B 102;LEU B  55;LEU B  75;LEU B 104;LEU B  74","None;None;39G B 401 (-4.3A);39G B 401 ( 4.7A);None","0.93A","1mx1C-4tyhB:undetectable","1mx1C-4tyhB:20.86"],["1MX1_F_THAF6_1","LIVER CARBOXYLESTERASE I","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"VAL B 102;LEU B  55;LEU B  75;LEU B 104;LEU B  74","None;None;39G B 401 (-4.3A);39G B 401 ( 4.7A);None","1.06A","1mx1F-4tyhB:undetectable","1mx1F-4tyhB:20.86"],["1XKK_A_FMMA91_2","EPIDERMAL GROWTH FACTOR RECEPTOR","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"VAL B  38;LYS B  53;LEU B  86;LEU B 104;LEU B 108;MET B 109","None;39G B 401 (-4.2A);None;39G B 401 ( 4.7A);39G B 401 ( 4.9A);39G B 401 (-4.8A)","0.68A","1xkkA-4tyhB:20.6","1xkkA-4tyhB:25.65"],["2IDK_A_C2FA1410_0","GLYCINE N-METHYLTRANSFERASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"LEU B 232;HIS B 228;SER B 254;TYR B 258;LEU B 236","None","1.49A","2idkA-4tyhB:undetectable;2idkB-4tyhB:undetectable;2idkC-4tyhB:undetectable;2idkD-4tyhB:undetectable","2idkA-4tyhB:22.19;2idkB-4tyhB:22.19;2idkC-4tyhB:22.19;2idkD-4tyhB:22.19"],["2IDK_B_C2FB1420_0","GLYCINE N-METHYLTRANSFERASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"LEU B 236;SER B 254;TYR B 258;LEU B 232;HIS B 228","None","1.36A","2idkA-4tyhB:1.2;2idkB-4tyhB:1.2;2idkC-4tyhB:0.0;2idkD-4tyhB:1.3","2idkA-4tyhB:22.19;2idkB-4tyhB:22.19;2idkC-4tyhB:22.19;2idkD-4tyhB:22.19"],["2ITZ_A_IREA2021_2","EPIDERMAL GROWTH FACTOR RECEPTOR","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",3,"LEU B 104;LEU B 108;MET B 109","39G B 401 ( 4.7A);39G B 401 ( 4.9A);39G B 401 (-4.8A)","0.51A","2itzA-4tyhB:21.7","2itzA-4tyhB:25.20"],["2QD2_A_CHDA426_0","FERROCHELATASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",4,"LEU B 246;PRO B 242;LEU B 291;ARG B 296","None","1.38A","2qd2A-4tyhB:undetectable","2qd2A-4tyhB:22.20"],["3CD2_A_MTXA307_1","DIHYDROFOLATE REDUCTASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"ILE B 131;LEU B 289;ILE B 206;LEU B 151;ILE B 212","None","1.16A","3cd2A-4tyhB:undetectable","3cd2A-4tyhB:19.32"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"GLU B  71;LEU B  74;LEU B  75;THR B 106;LEU B 167;ASP B 168","39G B 401 (-3.4A);None;39G B 401 (-4.3A);39G B 401 (-3.6A);39G B 401 (-3.6A);39G B 401 (-3.5A)","1.26A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"LEU B  75;ILE B  84;THR B 106;LEU B 167;ASP B 168","39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.6A);39G B 401 (-3.5A)","0.95A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",9,"VAL B  38;ALA B  51;GLU B  71;LEU B  74;LEU B  75;THR B 106;ILE B 141;HIS B 148;LEU B 167","None;39G B 401 (-3.5A);39G B 401 (-3.4A);None;39G B 401 (-4.3A);39G B 401 (-3.6A);None;None;39G B 401 (-3.6A)","0.95A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",8,"VAL B  38;ALA B  51;LEU B  75;ILE B  84;THR B 106;ILE B 141;HIS B 148;LEU B 167","None;39G B 401 (-3.5A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None;None;39G B 401 (-3.6A)","0.81A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GCS_A_BAXA401_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"VAL B 117;LEU B 164;ILE B 134;ILE B 141;HIS B 148","None","0.90A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GCS_A_BAXA401_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"MET B  78;VAL B  83;LEU B 108;ILE B 146;ILE B 166","None;None;39G B 401 ( 4.9A);None;None","0.62A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GCS_A_BAXA401_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"MET B  78;VAL B  83;LEU B 108;MET B 109;ILE B 166","None;None;39G B 401 ( 4.9A);39G B 401 (-4.8A);None","1.07A","3gcsA-4tyhB:29.9","3gcsA-4tyhB:98.28"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",8,"ALA B  51;GLU B  71;LEU B  74;LEU B  75;ILE B  84;ALA B 157;LEU B 167;ASP B 168","39G B 401 (-3.5A);39G B 401 (-3.4A);None;39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 ( 4.9A);39G B 401 (-3.6A);39G B 401 (-3.5A)","1.08A","3gp0A-4tyhB:41.1","3gp0A-4tyhB:75.00"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",8,"ALA B  51;GLU B  71;LEU B  74;LEU B  75;ILE B  84;HIS B 148;ALA B 157;LEU B 167","39G B 401 (-3.5A);39G B 401 (-3.4A);None;39G B 401 (-4.3A);39G B 401 ( 3.8A);None;39G B 401 ( 4.9A);39G B 401 (-3.6A)","0.85A","3gp0A-4tyhB:41.1","3gp0A-4tyhB:75.00"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",9,"VAL B  38;ALA B  51;LEU B  74;LEU B  75;ILE B  84;THR B 106;ALA B 157;LEU B 167;ASP B 168","None;39G B 401 (-3.5A);None;39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 ( 4.9A);39G B 401 (-3.6A);39G B 401 (-3.5A)","0.98A","3gp0A-4tyhB:41.1","3gp0A-4tyhB:75.00"],["3GP0_A_NILA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 11","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",9,"VAL B  38;ALA B  51;LEU B  74;LEU B  75;ILE B  84;THR B 106;HIS B 148;ALA B 157;LEU B 167","None;39G B 401 (-3.5A);None;39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None;39G B 401 ( 4.9A);39G B 401 (-3.6A)","0.90A","3gp0A-4tyhB:41.1","3gp0A-4tyhB:75.00"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"GLU B  71;LEU B  75;ILE B  84;LEU B 167;ASP B 168","39G B 401 (-3.4A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.5A)","0.79A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"LEU B  75;ILE B  84;THR B 106;LEU B 167;ASP B 168","39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.6A);39G B 401 (-3.5A)","0.81A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"LYS B  53;ILE B  84;THR B 106;LEU B 108;LEU B 167;ASP B 168","39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 ( 4.9A);39G B 401 (-3.6A);39G B 401 (-3.5A)","0.85A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;ALA B  51;LEU B  74;ILE B  84;THR B 106;LEU B 108;LEU B 167","None;39G B 401 (-3.5A);None;39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 ( 4.9A);39G B 401 (-3.6A)","0.59A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;ALA B  51;LEU B  74;LEU B  75;ILE B  84;THR B 106;LEU B 167","None;39G B 401 (-3.5A);None;39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.6A)","0.63A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;ALA B  51;LYS B  53;ILE B  84;THR B 106;LEU B 108;LEU B 167","None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 ( 4.9A);39G B 401 (-3.6A)","0.65A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEC_A_STIA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"VAL B  30;GLU B  71;LEU B  74;LEU B  75;ILE B  84;LEU B 167","None;39G B 401 (-3.4A);None;39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A)","0.66A","3hecA-4tyhB:41.0","3hecA-4tyhB:99.42"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;VAL B  38;ALA B  51;GLU B  71;LEU B  74;LEU B  75;ILE B 141","None;None;39G B 401 (-3.5A);39G B 401 (-3.4A);None;39G B 401 (-4.3A);None","0.84A","3hegA-4tyhB:42.1","3hegA-4tyhB:99.42"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;VAL B  38;ALA B  51;LEU B  74;LEU B  75;THR B 106;ILE B 141","None;None;39G B 401 (-3.5A);None;39G B 401 (-4.3A);39G B 401 (-3.6A);None","0.69A","3hegA-4tyhB:42.1","3hegA-4tyhB:99.42"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;VAL B  38;ALA B  51;LEU B  75;ILE B  84;THR B 106;ILE B 141","None;None;39G B 401 (-3.5A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None","0.57A","3hegA-4tyhB:42.1","3hegA-4tyhB:99.42"],["3HEG_A_BAXA1_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"VAL B  38;ALA B  51;LYS B  53;ILE B  84;THR B 106;ILE B 141","None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None","0.84A","3hegA-4tyhB:42.1","3hegA-4tyhB:99.42"],["3HEG_A_BAXA1_2","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"MET B  78;VAL B  83;ILE B 146;HIS B 148;ILE B 166;LEU B 167","None;None;None;None;None;39G B 401 (-3.6A)","0.63A","3hegA-4tyhB:42.1","3hegA-4tyhB:99.42"],["3IA4_A_MTXA164_1","DIHYDROFOLATE REDUCTASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"ALA B 302;GLN B 133;SER B 208;ILE B 212;LEU B 216","None","1.37A","3ia4A-4tyhB:undetectable","3ia4A-4tyhB:17.28"],["3JW3_A_TOPA208_1","DIHYDROFOLATE REDUCTASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"ALA B 302;LEU B 138;ILE B 212;LEU B 156;ILE B 131","None","1.08A","3jw3A-4tyhB:undetectable","3jw3A-4tyhB:17.97"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"ALA B  51;LYS B  53;THR B 106;LEU B 108;MET B 109","39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 (-3.6A);39G B 401 ( 4.9A);39G B 401 (-4.8A)","0.61A","3lfaA-4tyhB:42.6","3lfaA-4tyhB:99.43"],["3LFA_A_1N1A361_1","MITOGEN-ACTIVATED PROTEIN KINASE 14","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"VAL B  30;ALA B  51;LEU B 104;THR B 106;LEU B 108;MET B 109","None;39G B 401 (-3.5A);39G B 401 ( 4.7A);39G B 401 (-3.6A);39G B 401 ( 4.9A);39G B 401 (-4.8A)","0.54A","3lfaA-4tyhB:42.6","3lfaA-4tyhB:99.43"],["3OG7_A_032A1_1","AKAP9-BRAF FUSION PROTEIN","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"VAL B  38;ALA B  51;LYS B  53;LEU B  75;THR B 106","None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 (-4.3A);39G B 401 (-3.6A)","0.70A","3og7A-4tyhB:19.2","3og7A-4tyhB:25.91"],["3OHT_A_1N1A1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"GLY B  31;VAL B  38;ALA B  51;LEU B  75;ILE B  84;THR B 106;ASN B 114","None;None;39G B 401 (-3.5A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None","1.46A","3ohtA-4tyhB:34.3","3ohtA-4tyhB:86.49"],["3OHT_A_1N1A1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",9,"VAL B  30;GLY B  31;VAL B  38;ALA B  51;LYS B  53;LEU B  75;ILE B  84;THR B 106;LEU B 167","None;None;None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.6A)","0.86A","3ohtA-4tyhB:34.3","3ohtA-4tyhB:86.49"],["3OHT_A_1N1A1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"VAL B  30;GLY B  31;VAL B  38;LYS B  53;ILE B  84;LEU B 167;ASP B 168","None;None;None;39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.5A)","1.21A","3ohtA-4tyhB:34.3","3ohtA-4tyhB:86.49"],["3OHT_A_1N1A1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",9,"VAL B  30;VAL B  38;ALA B  51;LYS B  53;LEU B  75;ILE B  84;THR B 106;ASN B 115;LEU B 167","None;None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None;39G B 401 (-3.6A)","0.86A","3ohtA-4tyhB:34.3","3ohtA-4tyhB:86.49"],["3OHT_B_1N1B1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",7,"GLY B  31;VAL B  38;ALA B  51;LYS B  53;ILE B  84;THR B 106;LEU B 167","None;None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 (-3.6A)","0.77A","3ohtB-4tyhB:34.3","3ohtB-4tyhB:86.49"],["3OHT_B_1N1B1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"VAL B  38;ALA B  51;LEU B  75;ILE B  84;LEU B 167","None;39G B 401 (-3.5A);39G B 401 (-4.3A);39G B 401 ( 3.8A);39G B 401 (-3.6A)","0.45A","3ohtB-4tyhB:34.3","3ohtB-4tyhB:86.49"],["3OHT_B_1N1B1000_1","P38A","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",6,"VAL B  38;ALA B  51;LYS B  53;ILE B  84;THR B 106;ASN B 115","None;39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);None","0.85A","3ohtB-4tyhB:34.3","3ohtB-4tyhB:86.49"],["3PGL_A_RZXA257_1","CARBOXY-TERMINAL DOMAIN RNA POLYMERASE II POLYPEPTIDE A SMALL PHOSPHATASE 1","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"PHE B 169;VAL B  83;ILE B 166;SER B 143;TYR B 140","None","1.42A","3pglA-4tyhB:undetectable","3pglA-4tyhB:20.69"],["3QL0_A_FOLA160_0","DIHYDROFOLATE REDUCTASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"ALA B 302;MET B 288;LEU B 138;ILE B 212;LEU B 156","None","1.07A","3ql0A-4tyhB:undetectable","3ql0A-4tyhB:17.24"],["3UJ6_A_SAMA300_1","PHOSPHOETHANOLAMINE N-METHYLTRANSFERASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",4,"SER B  56;ASP B 168;ASP B 112;ALA B  34","None;39G B 401 (-3.5A);None;None","1.37A","3uj6A-4tyhB:undetectable","3uj6A-4tyhB:21.49"],["4K50_I_ACTI507_0","RNA POLYMERASE 3D-POL","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",3,"LYS B 152;PRO B 153;SER B 154","None","0.43A","4k50I-4tyhB:0.8","4k50I-4tyhB:21.83"],["4O8Z_A_BBIA402_1","NAD-DEPENDENT PROTEIN DEACETYLASE SIRTUIN-3, MITOCHONDRIAL","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",4,"PHE B  42;HIS B  48;LEU B  87;PRO B 351","None","1.30A","4o8zA-4tyhB:undetectable","4o8zA-4tyhB:21.87"],["4OU1_A_BEZA302_0","RETRO-ALDOLASE, DESIGN RA114","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",4,"LYS B 118;ILE B 116;ASN B 115;ALA B 111","None","0.91A","4ou1A-4tyhB:undetectable","4ou1A-4tyhB:22.69"],["4RZ7_A_1E8A901_1","CGMP-DEPENDENT PROTEIN KINASE, PUTATIVE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"ALA B  51;LYS B  53;ILE B  84;THR B 106;LEU B 108","39G B 401 (-3.5A);39G B 401 (-4.2A);39G B 401 ( 3.8A);39G B 401 (-3.6A);39G B 401 ( 4.9A)","0.83A","4rz7A-4tyhB:17.6","4rz7A-4tyhB:18.19"],["4UXQ_A_0LIA1752_2","FIBROBLAST GROWTH FACTOR RECEPTOR 4","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",4,"VAL B  38;LYS B  53;ILE B  84;ILE B 166","None;39G B 401 (-4.2A);39G B 401 ( 3.8A);None","0.79A","4uxqA-4tyhB:21.3","4uxqA-4tyhB:27.04"],["5HBS_A_RTLA201_1","RETINOL-BINDING PROTEIN 1","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",4,"LEU B  75;LEU B 167;TYR B 140;GLN B 202","39G B 401 (-4.3A);39G B 401 (-3.6A);None;None","1.19A","5hbsA-4tyhB:undetectable","5hbsA-4tyhB:17.95"],["5LW1_E_ADNE401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"GLY B  31;VAL B  38;ALA B  51;LEU B 108;MET B 109","None;None;39G B 401 (-3.5A);39G B 401 ( 4.9A);39G B 401 (-4.8A)","0.77A","5lw1E-4tyhB:36.8","5lw1E-4tyhB:11.21"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"GLY B  31;ALA B  51;LEU B 108;MET B 109;LEU B 167","None;39G B 401 (-3.5A);39G B 401 ( 4.9A);39G B 401 (-4.8A);39G B 401 (-3.6A)","0.80A","5lw1H-4tyhB:15.5","5lw1H-4tyhB:11.21"],["5LW1_H_ADNH401_1","MITOGEN-ACTIVATED PROTEIN KINASE 8","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"GLY B  31;VAL B  38;ALA B  51;LEU B 108;MET B 109","None;None;39G B 401 (-3.5A);39G B 401 ( 4.9A);39G B 401 (-4.8A)","0.77A","5lw1H-4tyhB:15.5","5lw1H-4tyhB:11.21"],["5YCN_A_8LXA501_0","PEROXISOME PROLIFERATOR-ACTIVATED RECEPTOR GAMMA","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",5,"LEU B 138;ILE B 206;GLY B 210;ILE B 131;LEU B 238","None","0.90A","5ycnA-4tyhB:undetectable","5ycnA-4tyhB:21.80"],["5ZW2_A_ACTA511_0","L-PROLYL-[PEPTIDYL-CARRIER PROTEIN] DEHYDROGENASE","4tyh","MITOGEN-ACTIVATED PROTEIN KINASE 14","Mus musculus",3,"ARG B 256;ILE B 250;SER B 252","None","0.84A","5zw2A-4tyhB:undetectable","5zw2A-4tyhB:22.72"]]